Logo image
SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation
Journal article   Open access   Peer reviewed

SPAK Deficiency Corrects Pseudohypoaldosteronism II Caused by WNK4 Mutation

Pei-Yi Chu, Chih-Jen Cheng, Yi-Chang Wu, Yu-Wei Fang, Tom Chau, Shinichi Uchida, Sei Sasaki, Sung-Sen Yang and Shih-Hua Lin
PloS one, Vol.8(9), pp.e72969-e72969
09/11/2013
DOI: 10.1371/journal.pone.0072969
PMCID: PMC3770638
PMID: 24039833
url
https://doi.org/10.1371/journal.pone.0072969View
Published (Version of record) Open Access

Abstract

Stimulation of the OSR1 (Oxidative stress-responsive kinase-1)/SPAK [STE20 (sterile 20)/SPS1-related proline/alanine-rich kinase]-NCC (Na+-Cl- cotransporter) signaling cascade plays an important role in the WNK [With-No-Lysine (K)] kinase 4 D561A knock-in mouse model of pseudohypoaldosteronism type II (PHA II) characterized by salt-sensitive hypertension and hyperkalemia. The aim of this study was to investigate the respective roles of Osr1 and Spak in the pathogenesis of PHA II in vivo. Wnk4(D561A/+) mice were crossed with kidney tubule-specific (KSP) Osr1 knockout (KSP-Osr1(-/-)) and Spak knockout (Spak(-/-)) mice. Blood pressure, plasma and urine biochemistries, and the relevant protein expression in the kidneys were examined. Wnk4(D561A/+), KSP-Osr1(-/-), and Spak(-/-) mice recapitulated the phenotypes of PHA II, Bartter-like syndrome, and Gitelman syndrome, respectively. Wnk4(D561A/+). KSP-Osr1(-/-) remained phenotypically PHA II while Wnk4(D561A/+). Spak(-/-) mice became normotensive and lacked the PHA II phenotype. Phosphorylated Spak and Ncc were similarly increased in both Wnk4(D561A/+) and Wnk4(D561A/+). KSP-Osr1(-/-) mice while phosphorylated Ncc normalized in Wnk4(D561A/+). Spak(-/-) mice. Furthermore, Wnk4(D561A/+). KSP-Osr1(-/-) mice exhibited exaggerated salt excretion in response to thiazide diuretics while Wnk4(D561A/+). Spak(-/-) mice exhibited normal responses. Wnk4(D561A/+). Spak (-/-). KSP-Osr1(-/-) triple mutant mice had low blood pressure and diminished phosphorylated Ncc. Both SPAK and OSR1 are important in the maintenance of blood pressure but activation of SPAK-NCC plays the dominant role in PHA II. SPAK may be a therapeutic target for disorders with salt-sensitive hypertension related to WNK4 activation.
Multidisciplinary Sciences Science & Technology Science & Technology - Other Topics

Details

Metrics

Logo image